FDA Still Most Predictable Part of Drug Development, Despite Bumps, Woodcock Says

Janet Woodcock may take a lot of criticism over problems with FDA’s drug application review and approval process, but she maintains sponsor success at gaining agency approval is better than any other portion of the development process.